2 October 2026
Learn about Vitality's GLP-1 obesity support and how it supports successful weight loss through assessments and personalised programs.
16 July 2026
Sun Pharma’s Generic Semaglutide is now available in South Africa. Explore this new treatment option for type 2 diabetes.
13 July 2026
Telehealth GLP-1 prescribing practices may expose patients to unsafe care, weak medical checks and compounded weight-loss drugs.
23 June 2026
iDexis semaglutide ban stops the pharmacy group from selling compounded weight-loss medicines while SAHPRA and the SAPC investigate.
29 March 2026
Learn how acknowledging obesity as a chronic disease can transform healthcare approaches and reduce long-term health costs.
23 March 2026
Learn how the advent of Generic Semaglutide in India will change the landscape of weight-loss and diabetes medications.
11 March 2026
Discover the potential of Generic Semaglutide Pricing, where new research shows significant savings on weight-loss medications.
9 February 2026
19 January 2026
Aspen Pharmacare is lining up a generic semaglutide launch in Canada, promising big discounts, and widening GLP-1 access.
14 January 2026
GLP-1 weight loss drugs like Mounjaro and Wegovy are transforming obesity treatment in SA amid rising health concerns and systemic barriers.
8 January 2026
Explore the benefits of the Wegovy weight-loss pill as a revolutionary option in managing obesity effectively.
11 November 2025
The landmark obesity drug deal announced by Trump aims to make weight management drugs more affordable for millions of patients.